Dr. Sulaiman Al Habib Medical Services Group
SAR 226.50Change from previous close: +3.24%Absolute change: +SAR 7.10
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- SAR 78.82B
- Enterprise value
- SAR 86.75B
- P/E (trailing 12 months)
- 32.6
- Forward P/E
- 30.0
- Price/book
- 9.54
- Price/sales
- 5.40
- EV/EBITDA
- 25.5
- EV/revenue
- 5.94
Profitability and growth
- Gross margin
- 29.3%
- Operating margin
- 19.2%
- Net margin
- 16.6%
- ROE
- 30.1%
- ROA
- 7.2%
- Revenue growth (year over year)
- 18.4%
- Earnings growth (year over year)
- 12.1%
Financial health
- Total cash
- SAR 2.32B
- Total debt
- SAR 9.67B
- Debt/equity
- 1.09
- Current ratio
- 1.12
- Quick ratio
- 0.77
Dividends
- Annual dividend per share
- SAR 5.32
- Dividend yield
- 2.4%
- Payout ratio
- 68.3%
- Ex-dividend date
- August 2, 2026
Analysts and estimates
- Average price target
- SAR 269.01
- Median price target
- SAR 273.00
- High price target
- SAR 310.00
- Low price target
- SAR 184.00
- Number of analysts
- 15
- Consensus
- Buy
- Forward EPS
- SAR 7.51
- EPS estimate, current year
- SAR 7.23
Shares and trading
- Beta
- 0.05
- Average volume
- 139.07K
- Shares outstanding
- 350M
- Float
- 101.99M
- Institutional ownership
- 4.4%
- Insider ownership
- 70.9%